| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Siegel is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Xu is Epidemiologist, Mortality Statistics Branch, Division of Vital Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
Ms. Smigal is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice-President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,399,790 new cancer cases and 564,830 deaths from cancer are expected in the United States in 2006. When deaths are aggregated by age, cancer has surpassed heart disease as the leading cause of death for those younger than age 85 since 1999. Delay-adjusted cancer incidence rates stabilized in men from 1995 through 2002, but continued to increase by 0.3% per year from 1987 through 2002 in women. Between 2002 and 2003, the actual number of recorded cancer deaths decreased by 778 in men, but increased by 409 in women, resulting in a net decrease of 369, the first decrease in the total number of cancer deaths since national mortality record keeping was instituted in 1930. The death rate from all cancers combined has decreased by 1.5% per year since 1993 among men and by 0.8% per year since 1992 among women. The mortality rate has also continued to decrease for the three most common cancer sites in men (lung and bronchus, colon and rectum, and prostate) and for breast and colon and rectum cancers in women. Lung cancer mortality among women continues to increase slightly. In analyses by race and ethnicity, African American men and women have 40% and 18% higher death rates from all cancers combined than White men and women, respectively. Cancer incidence and death rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites. However, these groups generally have higher rates for stomach, liver, and cervical cancers than Whites. Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites. Progress in reducing the burden of suffering and death from cancer can be accelerated by applying existing cancer control knowledge across all segments of the population.
This article has been cited by other articles:
|
|
 |
|
  T. Uto, Y. Takehara, Y. Nakamura, T. Naito, D. Hashimoto, N. Inui, T. Suda, H. Nakamura, and K. Chida Higher Sensitivity and Specificity for Diffusion-weighted Imaging of Malignant Lung Lesions without Apparent Diffusion Coefficient Quantification Radiology, July 1, 2009; 252(1): 247 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Ang, R. N. Shah, M. Everard, C. Keyzor, I. Coombes, A. Jenkins, K. Thomas, R. A'Hern, R. L. Jones, P. Blake, et al. A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma Ann. Onc., June 19, 2009; (2009) mdp193v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Haffty, D. H. Choi, S. Goyal, A. Silber, K. Ranieri, E. Matloff, M. H. Lee, M. Nissenblatt, D. Toppmeyer, and M. S. Moran Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups Ann. Onc., June 2, 2009; (2009) mdp051v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Diamanti-Kandarakis, J.-P. Bourguignon, L. C. Giudice, R. Hauser, G. S. Prins, A. M. Soto, R. T. Zoeller, and A. C. Gore Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement Endocr. Rev., June 1, 2009; 30(4): 293 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Brambilla and A. Gazdar Pathogenesis of lung cancer signalling pathways: roadmap for therapies Eur. Respir. J., June 1, 2009; 33(6): 1485 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. Campbell, S. Shah, and D. Gosselin Success with Men's Educational Group Appointments (MEGA): Subjective Improvements in Patient Education American Journal of Men's Health, June 1, 2009; 3(2): 173 - 178. [Abstract] [PDF]
|
|
|
|
 |
|
 R. E. Lewiss, T. Saul, and J. Teng Review Article: Gynecological Disorders in Geriatric Emergency Medicine American Journal of Hospice and Palliative Medicine, June 1, 2009; 26(3): 219 - 227. [Abstract] [PDF]
|
|
|
|
|
|
C.-Y. Chen, Y.-T. Kuo, C.-H. Lee, T.-J. Hsieh, C.-M. Jan, T.-S. Jaw, W.-T. Huang, and F.-J. Yu Differentiation between Malignant and Benign Gastric Ulcers: CT Virtual Gastroscopy versus Optical Gastroendoscopy Radiology, June 1, 2009; (2009) 2522081249. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-W. Jeong, H. S. Lee, K. Y. Lee, L. D. White, R. R. Broaddus, Y.-W. Zhang, G. F. Vande Woude, L. C. Giudice, S. L. Young, B. A. Lessey, et al. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease PNAS, May 26, 2009; 106(21): 8677 - 8682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Rahrmann, L. S. Collier, T. P. Knutson, M. E. Doyal, S. L. Kuslak, L. E. Green, R. L. Malinowski, L. Roethe, K. Akagi, M. Waknitz, et al. Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis Screen Cancer Res., May 15, 2009; 69(10): 4388 - 4397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ballard-Barbash, S. Hunsberger, M. H. Alciati, S. N. Blair, P. J. Goodwin, A. McTiernan, R. Wing, and A. Schatzkin Physical Activity, Weight Control, and Breast Cancer Risk and Survival: Clinical Trial Rationale and Design Considerations J Natl Cancer Inst, May 6, 2009; 101(9): 630 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Smith, S. K. Mithani, C. Liu, S. S. Chang, S. Begum, M. Dhara, W. Westra, D. Sidranksy, and J. A. Califano Novel Integrative Methods for Gene Discovery Associated With Head and Neck Squamous Cell Carcinoma Development Arch Otolaryngol Head Neck Surg, May 1, 2009; 135(5): 487 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bartling, M. Desole, S. Rohrbach, R.-E. Silber, and A. Simm Age-associated changes of extracellular matrix collagen impair lung cancer cell migration FASEB J, May 1, 2009; 23(5): 1510 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ren, Z. Chu, and L. Mao Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer Mol. Cancer Ther., May 1, 2009; 8(5): 1106 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Soliman, W. J. Aronson, and R. J. Barnard Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention Evid. Based Complement. Altern. Med., April 17, 2009; (2009) nep031v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Ocio, P. Maiso, X. Chen, M. Garayoa, S. Alvarez-Fernandez, L. San-Segundo, D. Vilanova, L. Lopez-Corral, J. C. Montero, T. Hernandez-Iglesias, et al. Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks Blood, April 16, 2009; 113(16): 3781 - 3791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Borczuk, R. L. Toonkel, and C. A. Powell Genomics of Lung Cancer Proceedings of the ATS, April 15, 2009; 6(2): 152 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Anderson, M.-Y. Lam, C. Poirier, C. E. Bishop, and J. H. Nadeau The Role of the Mouse Y Chromosome on Susceptibility to Testicular Germ Cell Tumors Cancer Res., April 15, 2009; 69(8): 3614 - 3618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Balog The Moral Justification for a Compulsory Human Papillomavirus Vaccination Program Am J Public Health, April 1, 2009; 99(4): 616 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Camp, J. M. Farnham, J. Wong, G. B. Christensen, A. Thomas, and L. A. Cannon-Albright Replication of the 10q11 and Xp11 Prostate Cancer Risk Variants: Results from a Utah Pedigree-Based Study Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1290 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chakravarty, A. A. Santillan, C. Galer, H. P. Adams, A. K. El-Naggar, S. A. Jasser, S. Mohsin, D. Mondal, G. L. Clayman, and J. N. Myers Phosphorylated Insulin Like Growth Factor-I Receptor Expression and Its Clinico-Pathological Significance in Histologic Subtypes of Human Thyroid Cancer Experimental Biology and Medicine, April 1, 2009; 234(4): 372 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Elsasser-Beile, G. Reischl, S. Wiehr, P. Buhler, P. Wolf, K. Alt, J. Shively, M. S. Judenhofer, H.-J. Machulla, and B. J. Pichler PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen J. Nucl. Med., April 1, 2009; 50(4): 606 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Horst, S. K. Gruvberger-Saal, B. D. Hopkins, L. Bordone, Y. Yang, K. A. Chernoff, I. Uzoma, V. Schwipper, J. Liebau, N. J. Nowak, et al. Gab2-Mediated Signaling Promotes Melanoma Metastasis Am. J. Pathol., April 1, 2009; 174(4): 1524 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sakamoto, S. Maeda, Y. Hikiba, H. Nakagawa, Y. Hayakawa, W. Shibata, A. Yanai, K. Ogura, and M. Omata Constitutive NF-{kappa}B Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth Clin. Cancer Res., April 1, 2009; 15(7): 2248 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. McWilliams, B. Lam, and T. Sutedja Early proximal lung cancer diagnosis and treatment Eur. Respir. J., March 1, 2009; 33(3): 656 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-G. Fan, P. Hu, Y. Jiang, R.-S. Chang, S.-X. Yao, W. Wang, J. He, P. Prorok, and Y.-L. Qiao Association Between Sputum Atypia and Lung Cancer Risk in an Occupational Cohort in Yunnan, China Chest, March 1, 2009; 135(3): 778 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-F. Wong Dasatinib dosing strategies in Philadelphia chromosome-positive leukemia Journal of Oncology Pharmacy Practice, March 1, 2009; 15(1): 17 - 27. [Abstract] [PDF]
|
|
|
|
|
|
C.-H. Hsu, J. M.G. Taylor, Q. Long, and D. S. Alberts Analysis of Colorectal Adenoma Recurrence Data Subject to Informative Censoring Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 712 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bapat, N. M. Lindor, J. Baron, K. Siegmund, L. Li, Y. Zheng, R. Haile, S. Gallinger, J. R. Jass, J. P. Young, et al. The Association of Tumor Microsatellite Instability Phenotype with Family History of Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 967 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. NAKAMURA, J. WADA, H. SUZUKI, M. TANAKA, M. KATANO, and T. MORISAKI Long-term Outcome of Immunotherapy for Patients with Refractory Pancreatic Cancer Anticancer Res, March 1, 2009; 29(3): 831 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sartore-Bianchi, M. Martini, F. Molinari, S. Veronese, M. Nichelatti, S. Artale, F. Di Nicolantonio, P. Saletti, S. De Dosso, L. Mazzucchelli, et al. PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies Cancer Res., March 1, 2009; 69(5): 1851 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. O. Lewis, M. G. Ozawa, M. T. Deavers, G. Wang, T. Shintani, W. Arap, and R. Pasqualini The Interleukin-11 Receptor {alpha} as a Candidate Ligand-Directed Target in Osteosarcoma: Consistent Data from Cell Lines, Orthotopic Models, and Human Tumor Samples Cancer Res., March 1, 2009; 69(5): 1995 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Onozawa, S. Murata, A. Shimizu, H. Tajima, F. Hidaka, S.-i. Kumita, and K. Nomura Comparative Study of Transcatheter Renal Arterial Embolization with and without Closed Renal Circuit: Pharmacokinetic and Histologic Assessment in Pigs Radiology, March 1, 2009; 250(3): 714 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pectasides, U. Dafni, D. Bafaloukos, D. Skarlos, A. Polyzos, D. Tsoutsos, H. Kalofonos, G. Fountzilas, P. Panagiotou, G. Kokkalis, et al. Randomized Phase III Study of 1 Month Versus 1 Year of Adjuvant High-Dose Interferon Alfa-2b in Patients With Resected High-Risk Melanoma J. Clin. Oncol., February 20, 2009; 27(6): 939 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Ostrow, H. L. Park, M. O. Hoque, M. S. Kim, J. Liu, P. Argani, W. Westra, W. V. Criekinge, and D. Sidransky Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer Clin. Cancer Res., February 15, 2009; 15(4): 1184 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schulte, B. Schniewind, P. Dohrmann, T. Kuchler, and R. Kurdow The Extent of Lung Parenchyma Resection Significantly Impacts Long-Term Quality of Life in Patients With Non-Small Cell Lung Cancer Chest, February 1, 2009; 135(2): 322 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Kang, K. W. Lee, B. J. Shin, S. K. Jung, M. K. Hwang, A. M. Bode, Y.-S. Heo, H. J. Lee, and Z. Dong Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression Carcinogenesis, February 1, 2009; 30(2): 321 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Chauhan, K. Vannatta, M. C. Ebeling, N. Vinayek, A. Watanabe, K. K. Pandey, M. C. Bell, M. D. Koch, H. Aburatani, Y. Lio, et al. Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer Cancer Res., February 1, 2009; 69(3): 765 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bitik, Y. Kalpakci, E. Altan, E. Dogan, and K. Altundag Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel-cisplatin-5-fluorouracil regimen Ann. Onc., February 1, 2009; 20(2): 394 - 395. [Full Text] [PDF]
|
|
|
|
|
|
J.-P. DELORD, C. PUOZZO, F. LEFRESNE, and R. BUGAT Combination Chemotherapy of Vinorelbine and Cisplatin: A Phase I Pharmacokinetic Study in Patients with Metastatic Solid Tumors Anticancer Res, February 1, 2009; 29(2): 553 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Martelli, G. Sozzi, L. Hernandez, V. Pettirossi, A. Navarro, D. Conte, P. Gasparini, F. Perrone, P. Modena, U. Pastorino, et al. EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues Am. J. Pathol., February 1, 2009; 174(2): 661 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Murphy, A. C. Spalding, Y. R. Somnay, S. Markwart, M. E. Ray, and D. A. Hamstra Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature Clin. Cancer Res., January 15, 2009; 15(2): 589 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kim, N. H. Park, H. G. Wu, J. Y. Cho, H. H. Chung, J. W. Kim, Y. S. Song, S. H. Kim, and S. B. Kang Matched-Case Comparison for the Role of Surgery in FIGO Stage Ib1-IIa Squamous Cell Carcinoma of Cervix and Suspicious Para-Aortic Lymph Node Metastasis Ann. Surg. Oncol., January 1, 2009; 16(1): 133 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Adams, K. P. Claffey, and B. A. White Argonaute-2 Expression Is Regulated by Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling and Correlates with a Transformed Phenotype in Breast Cancer Cells Endocrinology, January 1, 2009; 150(1): 14 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nicolaiew, G. Cancel-Tassin, A. R. Azzouzi, B. L. Grand, P. Mangin, L. Cormier, G. Fournier, J.-P. Giordanella, M. Pouchard, J.-L. Escary, et al. Association between estrogen and androgen receptor genes and prostate cancer risk Eur. J. Endocrinol., January 1, 2009; 160(1): 101 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lai, S. A. Myers, M. G. Lawrence, D. M. Odorico, and J. A. Clements Direct Progesterone Receptor and Indirect Androgen Receptor Interactions with the Kallikrein-Related Peptidase 4 Gene Promoter in Breast and Prostate Cancer Mol. Cancer Res., January 1, 2009; 7(1): 129 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Nakajima, A. Matsunaga, D. Ichimaru, Y. Urata, T. Fujiwara, and K. Kawakami Telomerase-specific virotherapy in an animal model of human head and neck cancer Mol. Cancer Ther., January 1, 2009; 8(1): 171 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. AGUZZI, D. MAGGIONI, G. NICOLINI, G. TREDICI, R. M. GAINI, and W. GARAVELLO MAP Kinase Modulation in Squamous Cell Carcinoma of the Oral Cavity Anticancer Res, January 1, 2009; 29(1): 303 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Roepman, J. Jassem, E. F. Smit, T. Muley, J. Niklinski, T. van de Velde, A. T. Witteveen, W. Rzyman, A. Floore, S. Burgers, et al. An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non-Small-Cell Lung Cancer Clin. Cancer Res., January 1, 2009; 15(1): 284 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-h. Chang, M. L. Lindegren, M. A. Butler, S. J. Chanock, N. F. Dowling, M. Gallagher, R. Moonesinghe, C. A. Moore, R. M. Ned, M. R. Reichler, et al. Prevalence in the United States of Selected Candidate Gene Variants: Third National Health and Nutrition Examination Survey, 1991-1994 Am. J. Epidemiol., January 1, 2009; 169(1): 54 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Higano, M. M. Cherrier, S. Aubin, and B. L. Dalkin Effects of Prostate Cancer Treatments on Sexual Health and Cognition ASCO Educational Book, January 1, 2009; 2009(1): 257 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Setoguchi, C. C. Earle, R. Glynn, M. Stedman, J. M. Polinski, C. P. Corcoran, and J. S. Haas Comparison of Prospective and Retrospective Indicators of the Quality of End-of-Life Cancer Care J. Clin. Oncol., December 10, 2008; 26(35): 5671 - 5678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Beddy, J. M. P. Hyland, D. C. Winter, C. Lim, A. White, M. Moriarty, J. Armstrong, D. Fennelly, D. Gibbons, and K. Sheahan A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy Ann. Surg. Oncol., December 1, 2008; 15(12): 3471 - 3477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Hassett, M. E. Hughes, J. C. Niland, S. B. Edge, R. L. Theriault, Y.-N. Wong, J. Wilson, W. B. Carter, D. W. Blayney, and J. C. Weeks Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer J. Clin. Oncol., December 1, 2008; 26(34): 5553 - 5560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Brignardello, A. Corrias, G. Isolato, N. Palestini, L. Cordero di Montezemolo, F. Fagioli, and G. Boccuzzi Ultrasound Screening for Thyroid Carcinoma in Childhood Cancer Survivors: A Case Series J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4840 - 4843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mohyuddin, A. Langerman, C. LeHew, L. Kaste, and K. Pytynia Knowledge of Head and Neck Cancer Among Medical Students at 2 Chicago Universities Arch Otolaryngol Head Neck Surg, December 1, 2008; 134(12): 1294 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kim-Schulze, H. S. Kim, A. Wainstein, D. W. Kim, W. C. Yang, D. Moroziewicz, P. Y. Mong, M. Bereta, B. Taback, Q. Wang, et al. Intrarectal Vaccination with Recombinant Vaccinia Virus Expressing Carcinoembronic Antigen Induces Mucosal and Systemic Immunity and Prevents Progression of Colorectal Cancer J. Immunol., December 1, 2008; 181(11): 8112 - 8119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ordonez-Moran, M. J. Larriba, H. G. Palmer, R. A. Valero, A. Barbachano, M. Dunach, A. G. de Herreros, C. Villalobos, M. T. Berciano, M. Lafarga, et al. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells J. Cell Biol., November 17, 2008; 183(4): 697 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rayhman, E. Klipper, L. Muller, B. Davidson, R. Reich, and R. Meidan Small Interfering RNA Molecules Targeting Endothelin-Converting Enzyme-1 Inhibit Endothelin-1 Synthesis and the Invasive Phenotype of Ovarian Carcinoma Cells Cancer Res., November 15, 2008; 68(22): 9265 - 9273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tanaka, M. Ikeda, T. Okusaka, H. Ueno, C. Morizane, A. Hagihara, S. Iwasa, and Y. Kojima Prognostic Factors in Japanese Patients with Advanced Pancreatic Cancer Treated with Single-agent Gemcitabine as First-line Therapy Jpn. J. Clin. Oncol., November 1, 2008; 38(11): 755 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tassi, F. Gavazzi, L. Albarello, V. Senyukov, R. Longhi, P. Dellabona, C. Doglioni, M. Braga, V. Di Carlo, and M. P. Protti Carcinoembryonic Antigen-Specific but Not Antiviral CD4+ T Cell Immunity Is Impaired in Pancreatic Carcinoma Patients J. Immunol., November 1, 2008; 181(9): 6595 - 6603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Liang, H. Wang, A. Rashid, T.-H. Tan, R. F. Hwang, S. R. Hamilton, J. L. Abbruzzese, D. B. Evans, and H. Wang Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma Clin. Cancer Res., November 1, 2008; 14(21): 7043 - 7049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Xiao, A. A. Powolny, and S. V. Singh Benzyl Isothiocyanate Targets Mitochondrial Respiratory Chain to Trigger Reactive Oxygen Species-dependent Apoptosis in Human Breast Cancer Cells J. Biol. Chem., October 31, 2008; 283(44): 30151 - 30163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Abrams, P. C. Lee, J. L. Port, N. K. Altorki, and A. I. Neugut Cigarette Smoking and Risk of Lung Metastasis from Esophageal Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2707 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lahat, D. Tuvin, C. Wei, D. A. Anaya, B. N. Bekele, A. J. Lazar, P. W. Pisters, D. Lev, and R. E. Pollock New Perspectives for Staging and Prognosis in Soft Tissue Sarcoma Ann. Surg. Oncol., October 1, 2008; 15(10): 2739 - 2748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Wirth, J. F. Krane, Y. Li, M. Othus, A. E. Moran, D. M. Dorfman, C. M. Norris Jr, L. Goguen, M. R. Posner, R. I. Haddad, et al. A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions Cancer Prevention Research, October 1, 2008; 1(5): 339 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nemenoff, A. M. Meyer, T. M. Hudish, A. B. Mozer, A. Snee, S. Narumiya, R. S. Stearman, R. A. Winn, M. Weiser-Evans, M. W. Geraci, et al. Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator-Activated Receptor {gamma} Cancer Prevention Research, October 1, 2008; 1(5): 349 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Feldmann, N Habbe, S Dhara, S Bisht, H Alvarez, V Fendrich, R Beaty, M Mullendore, C Karikari, N Bardeesy, et al. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer Gut, October 1, 2008; 57(10): 1420 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Behrens, H. Y. Lin, J. J. Lee, M. G. Raso, W. K. Hong, I. I. Wistuba, and R. Lotan Immunohistochemical Expression of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptors 1 and 2 in the Pathogenesis of Lung Cancer Clin. Cancer Res., October 1, 2008; 14(19): 6014 - 6022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Stan, E.-R. Hahm, R. Warin, and S. V. Singh Withaferin A Causes FOXO3a- and Bim-Dependent Apoptosis and Inhibits Growth of Human Breast Cancer Cells In vivo Cancer Res., September 15, 2008; 68(18): 7661 - 7669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Narita, A. So, S. Ettinger, N. Hayashi, M. Muramaki, L. Fazli, Y. Kim, and M. E. Gleave GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate Cancer Clin. Cancer Res., September 15, 2008; 14(18): 5769 - 5777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A F van Rijn, L G M van Rossum, M Deutekom, R J F Laheij, P M M Bossuyt, P Fockens, E Dekker, and J B M J Jansen Getting adequate information across to colorectal cancer screening subjects can be difficult J Med Screen, September 1, 2008; 15(3): 149 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Tinder, D. B. Subramani, G. D. Basu, J. M. Bradley, J. Schettini, A. Million, T. Skaar, and P. Mukherjee MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma J. Immunol., September 1, 2008; 181(5): 3116 - 3125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Xiong, S. Gharagozlou, I. Vengco, W. Chen, and J. R. Ohlfest Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis Clin. Cancer Res., September 1, 2008; 14(17): 5484 - 5493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Raz, M. R. Ray, J. Y. Kim, B. He, M. Taron, M. Skrzypski, M. Segal, D. R. Gandara, R. Rosell, and D. M. Jablons A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma Clin. Cancer Res., September 1, 2008; 14(17): 5565 - 5570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Addla, M. D. Brown, C. A. Hart, V. A. C. Ramani, and N. W. Clarke Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells Am J Physiol Renal Physiol, September 1, 2008; 295(3): F680 - F687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Donovan, S. Hamann, M. Clayton, F. M. Khan, M. Sapir, V. Bayer-Zubek, G. Fernandez, R. Mesa-Tejada, M. Teverovskiy, V. E. Reuter, et al. Systems Pathology Approach for the Prediction of Prostate Cancer Progression After Radical Prostatectomy J. Clin. Oncol., August 20, 2008; 26(24): 3923 - 3929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Brewster, G. N. Hortobagyi, K. R. Broglio, S.-W. Kau, C. A. Santa-Maria, B. Arun, A. U. Buzdar, D. J. Booser, V. Valero, M. Bondy, et al. Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy J Natl Cancer Inst, August 20, 2008; 100(16): 1179 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Ransohoff, C. Martin, W. S. Wiggins, B. A. Hitt, T. O. Keku, J. A. Galanko, and R. S. Sandler Assessment of Serum Proteomics to Detect Large Colon Adenomas Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2188 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gianni, E. H. Herman, S. E. Lipshultz, G. Minotti, N. Sarvazyan, and D. B. Sawyer Anthracycline Cardiotoxicity: From Bench to Bedside J. Clin. Oncol., August 1, 2008; 26(22): 3777 - 3784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Seo, D. D. Liu, B. N. Bekele, M.-K. Kim, K. Pisters, S. M. Lippman, I. I. Wistuba, and J. S. Koo Cyclic AMP Response Element-Binding Protein Overexpression: A Feature Associated with Negative Prognosis in Never Smokers with Non-Small Cell Lung Cancer Cancer Res., August 1, 2008; 68(15): 6065 - 6073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Teng, Z.-Y. Wang, E. R. Prossnitz, and D. E. Bjorling The G Protein-Coupled Receptor GPR30 Inhibits Human Urothelial Cell Proliferation Endocrinology, August 1, 2008; 149(8): 4024 - 4034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Heusner, S. Kuemmel, L. Umutlu, A. Koeninger, L. S. Freudenberg, E. A.M. Hauth, K. R. Kimmig, M. Forsting, A. Bockisch, and G. Antoch Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography J. Nucl. Med., August 1, 2008; 49(8): 1215 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Patel, R. Mick, J. Finlay, T. C. Zhu, E. Rickter, K. A. Cengel, S. B. Malkowicz, S. M. Hahn, and T. M. Busch Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen Clin. Cancer Res., August 1, 2008; 14(15): 4869 - 4876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. McKibbin, C. R. Frei, R. E. Greene, P. Kwan, J. Simon, and J. M. Koeller Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting Oncologist, August 1, 2008; 13(8): 876 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Corsini, R. C. Miller, M. G. Haddock, J. H. Donohue, M. B. Farnell, D. M. Nagorney, A. Jatoi, R. R. McWilliams, G. P. Kim, S. Bhatia, et al. Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005) J. Clin. Oncol., July 20, 2008; 26(21): 3511 - 3516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chaiswing, W. Zhong, J. J. Cullen, L. W. Oberley, and T. D. Oberley Extracellular Redox State Regulates Features Associated with Prostate Cancer Cell Invasion Cancer Res., July 15, 2008; 68(14): 5820 - 5826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Govindarajan, N. Fraser, V. Cranford, D. Wirtzfeld, S. Gallinger, C. H. L. Law, A. J. Smith, and A. R. Gagliardi Predictors of Multivisceral Resection in Patients with Locally Advanced Colorectal Cancer Ann. Surg. Oncol., July 1, 2008; 15(7): 1923 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. S. Park, M. Y. Jin, Y. J. Kim, J. H. Yook, B. S. Kim, and S. J. Jang The Global Histone Modification Pattern Correlates with Cancer Recurrence and Overall Survival in Gastric Adenocarcinoma Ann. Surg. Oncol., July 1, 2008; 15(7): 1968 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Park, D.-Y. Kim, D.-S. Suh, J.-H. Kim, Y.-M. Kim, Y.-T. Kim, and J.-H. Nam Comparison of Laparoscopy and Laparotomy in Surgical Staging of Early-Stage Ovarian and Fallopian Tubal Cancer Ann. Surg. Oncol., July 1, 2008; 15(7): 2012 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. L. Choi, K. Takeuchi, M. Soda, K. Inamura, Y. Togashi, S. Hatano, M. Enomoto, T. Hamada, H. Haruta, H. Watanabe, et al. Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non-Small Cell Lung Cancer Cancer Res., July 1, 2008; 68(13): 4971 - 4976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nocito, F. Dahm, W. Jochum, J. H. Jang, P. Georgiev, M. Bader, R. Graf, and P.-A. Clavien Serotonin Regulates Macrophage-Mediated Angiogenesis in a Mouse Model of Colon Cancer Allografts Cancer Res., July 1, 2008; 68(13): 5152 - 5158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Dehm, L. J. Schmidt, H. V. Heemers, R. L. Vessella, and D. J. Tindall Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance Cancer Res., July 1, 2008; 68(13): 5469 - 5477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bonome, D. A. Levine, J. Shih, M. Randonovich, C. A. Pise-Masison, F. Bogomolniy, L. Ozbun, J. Brady, J. C. Barrett, J. Boyd, et al. A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer Cancer Res., July 1, 2008; 68(13): 5478 - 5486. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
